Literature DB >> 17187781

Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6/1 and R6/2 mouse models of Huntington's disease.

Karin van der Borght1, Patrik Brundin.   

Abstract

Cognitive deficits and impaired olfactory function are observed in early stages of Huntington's disease (HD). The polysialylated form of the neural cell adhesion molecule (PSA-NCAM) is strongly associated with plastic events in the brain. During adulthood, it is most abundantly expressed in the hippocampus and the piriform cortex, which are involved in cognition and olfaction, respectively. We show that the numbers of PSA-NCAM-positive cells in the hippocampus and piriform cortex are dramatically reduced in the R6/1 and the R6/2 mouse models of HD. We hypothesize that the decrease in NCAM polysialylation reflects an impaired plasticity and might underlie some of the early symptoms in HD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17187781     DOI: 10.1016/j.expneurol.2006.10.014

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  9 in total

1.  Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington's Disease.

Authors:  Glenn M Dallérac; Damian M Cummings; Mark C Hirst; Austen J Milnerwood; Kerry P S J Murphy
Journal:  Neuromolecular Med       Date:  2016-01-18       Impact factor: 3.843

2.  Morphometrical study of polysialylated neural cell adhesion molecule positive cells in rat pups hippocampus following induction of seizure during pregnancy.

Authors:  Ali Akbar Rajabzadeh; Ali Reza Ebrahimzadeh Bideskan; Hossein Haghir; Ali Reza Fazel
Journal:  Iran Biomed J       Date:  2011

3.  Doublecortin-expressing cells are present in layer II across the adult guinea pig cerebral cortex: partial colocalization with mature interneuron markers.

Authors:  Kun Xiong; Duan-Wu Luo; Peter R Patrylo; Xue-Gang Luo; Robert G Struble; Richard W Clough; Xiao-Xin Yan
Journal:  Exp Neurol       Date:  2008-02-23       Impact factor: 5.330

4.  FGF2 and dual agonist of NCAM and FGF receptor 1, Enreptin, rescue neurite outgrowth loss in hippocampal neurons expressing mutated huntingtin proteins.

Authors:  Mirolyuba Ilieva; Troels T Nielsen; Tanja Michel; Stanislava Pankratova
Journal:  J Neural Transm (Vienna)       Date:  2019-09-09       Impact factor: 3.575

5.  The effect of PTZ-induced epileptic seizures on hippocampal expression of PSA-NCAM in offspring born to kindled rats.

Authors:  Aliakbar Rajabzadeh; Alireza Ebrahimzadeh Bideskan; Alireza Fazel; Mojtaba Sankian; Houshang Rafatpanah; Hossein Haghir
Journal:  J Biomed Sci       Date:  2012-05-31       Impact factor: 8.410

6.  Distinctive PSA-NCAM and NCAM hallmarks in glutamate-induced dendritic atrophy and synaptic disassembly.

Authors:  María Fernanda Podestá; Patricia Yam; Martín Gabriel Codagnone; Nonthué Alejandra Uccelli; David Colman; Analía Reinés
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

7.  Inhibition of DREAM-ATF6 interaction delays onset of cognition deficit in a mouse model of Huntington's disease.

Authors:  Alejandro López-Hurtado; Daniel F Burgos; Paz González; Xose M Dopazo; Valentina González; Alberto Rábano; Britt Mellström; Jose R Naranjo
Journal:  Mol Brain       Date:  2018-03-09       Impact factor: 4.041

8.  Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease.

Authors:  Alba Di Pardo; Vittorio Maglione
Journal:  Neural Regen Res       Date:  2017-09       Impact factor: 5.135

9.  The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease.

Authors:  Rachel Y Cheong; Sanaz Gabery; Åsa Petersén
Journal:  J Huntingtons Dis       Date:  2019
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.